Merican Society’s Stance on Each Bill

H.R. 80 Triple Negative Breast Cancer Research and Education Act of 2013:
ACS CAN has not taken a position on this bill, but supports NIH and NCI research on triple negative breast cancer research.   NCI has identified research in this area a priority for the institute and so our focus has been increasing research at the NIH to make additional progress in cancer prevention and treatment which will have a bigger impact on breast and other types of cancer. As part of ACS CAN’s major campaign to make funding the fight against cancer a national priority, we are advocating to sustain and increase funding for cancer research through NIH and NCI.H.R. 1984 Breast Cancer Patient Education Act of 2013 and S. 931 Breast Cancer Patient Education Act of 2013:

We have supported the Breast Cancer Protection Act. ACS CAN and the Society have strongly supported the ability of a physician and patient to freely discuss and decide together what treatment, including length of hospital stay, is medically necessary and appropriate for the patient. To that end, ACS CAN opposes any effort on the part of a health plan or health insurance organization that seeks to arbitrarily limit patient access to available treatments deemed medically necessary by a physician.  While the expanded coverage the Breast Cancer Patient Protection Act would provide is very important, it addresses only a small part of the existing barriers to accessing quality breast cancer care.  Significant health disparities still exist that prevent access to care altogether.  ACS CAN has found that it can make a larger impact on women’s health by focusing on other issues related to breast cancer, such as by supporting the National Breast & Cervical Cancer Early Detection Program, which delivers screening services to underserved women.  In addition, ACS CAN is working to secure additional funding for this program to help ensure that all women have access to mammograms and lifesaving treatment services.

H.R. 1830 Accelerating the End of Breast Cancer 2013  and S. 865 Accelerating the End of Breast Cancer 2013:

We have not taken a position on this bill since it creates a separate advisory board for breast cancer.  Our longstanding position is that we do not support earmark funding at NIH or make changes to the peer-review process that NIH undertakes to evaluate research grants. Instead ACS CAN has advocated for appropriate federal funds appropriated to the NIH.

Comments

Popular posts from this blog

The Fleshlight is easy to replace a partner - Paint Her Pink

Pretty Little Magic